Information Provided By: 
Fly News Breaks for August 1, 2019
PEN
Aug 1, 2019 | 07:12 EDT
Wells Fargo analyst Lawrence Biegelsen raised his price target for Penumbra to $185 from $180 ahead of quarterly results. Based on his recent conversations with key opinion leaders and attendance at the Society of NeuroInterventional Surgeon meeting, the analyst believes the stroke market growth momentum remains strong and the company is well positioned to remain a leader in the field. He reiterates an Outperform rating on the shares.
News For PEN From the Last 2 Days
There are no results for your query PEN
